Feed Preview

Vascular Dementia

Vascular Dementia diagram by Atthapon Raksthaput, Shutterstock
Atthapon Raksthaput, Shutterstock

Vascular Dementia refers to the decline in thinking ability caused by cerebrovascular diseases. Discover the latest research on aspects underlying vascular dementia here.

Top 20 most recent papers
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

Which factors can we control the transition from mild cognitive impairment to dementia?

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of AustralasiaJanuary 30, 2020
Mehlika Panpalli Ates, Fatma Yilmaz Can
1
Journal of Medicine and Life

Possibilities of Dementia Prevention - It is Never Too Early to Start

Journal of Medicine and LifeFebruary 7, 2020
Sandra MorovicVida Demarin
Journal of Translational Medicine

Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial

Journal of Translational MedicineFebruary 15, 2020
Jing ShiCHASE Study Group
1
Behavioural Brain Research

Exercise effects on brain and behavior in healthy mice, Alzheimer's disease and Parkinson's disease model - a systematic review and meta-analysis

Behavioural Brain ResearchJanuary 29, 2020
Thiago Medeiros da Costa DanieleVeralice Meireles Sales de Bruin
4
1
Annals of Translational Medicine

Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the NOTCH3

Annals of Translational MedicineFebruary 15, 2020
Chen-Si LiLe Fang
Neuro-degenerative Diseases

Potential Mechanism of Venous System for Leukoaraiosis: From post-mortem to in vivo Research

Neuro-degenerative DiseasesFebruary 12, 2020
Di NanJiachun Feng
1
NeuroImage

Cardiac and respiration-induced brain deformations in humans quantified with high-field MRI

NeuroImageJanuary 27, 2020
Jacob-Jan SlootsJaco J M Zwanenburg
Neuropsychiatric Disease and Treatment

Alcohol and Dementia - What is the Link? A Systematic Review

Neuropsychiatric Disease and TreatmentFebruary 6, 2020
Caspar WiegmannStefan Gutwinski
14
1
Journal of Neurology

Microbleeds in dementia with Lewy bodies

Journal of NeurologyFebruary 5, 2020
Paul C DonaghyJohn T O'Brien
1
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine

Nighttime hypoxia affects global cognition, memory, and executive function in community-dwelling individuals with hypertension

Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep MedicineJanuary 30, 2020
Iolanda Riba-LlenaPilar Delgado
1
Annals of Palliative Medicine

Plasma parameters and risk factors of patients with post-stroke cognitive impairment

Annals of Palliative MedicineFebruary 2, 2020
Ji-Xia WuChun-Feng Liu

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/vascular-dementia/61137a20-82ff-4ffe-b807-bc3f4e595435